Your browser doesn't support javascript.
loading
A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy.
Lin, Zhong-Zhe; Chen, Bang-Bin; Hung, Yi-Ping; Huang, Po-Hsiang; Shen, Ying-Chun; Shao, Yu-Yun; Hsu, Chih-Hung; Cheng, Ann-Lii; Lee, Rheun-Chuan; Chao, Yee; Hsu, Chiun.
Afiliação
  • Lin ZZ; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.
  • Chen BB; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  • Hung YP; Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Huang PH; Department of Radiology, National Taiwan University Hospital, Taipei, Taiwan.
  • Shen YC; Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Shao YY; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  • Hsu CH; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.
  • Cheng AL; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  • Lee RC; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Chao Y; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  • Hsu C; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.
Oncologist ; 25(9): e1280-e1285, 2020 09.
Article em En | MEDLINE | ID: mdl-32271494

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Taiwan

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Taiwan